Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2020-02-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$135.4m
reported value
18positions
91.4%in top 10
—no comparable previous quarter
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $46.6m34.43% | — |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $27.6m20.34% | — |
| APPLIED THERAPEUTICS INC APLT | $12.7m9.41% | — |
| ABEONA THERAPEUTICS INC COM | $9.4m6.90% | — |
| BLACKSTONE GROUP L P BX | $8.5m6.29% | — |
| EIGER BIOPHARMACEUTICALS INC CLDN | $5.2m3.85% | — |
| EXICURE INC XCUR | $3.7m2.70% | — |
| ENTERA BIO LTD ENTX | $3.6m2.66% | — |
| ALDEYRA THERAPEUTICS INC ALDX | $3.3m2.44% | — |
| KRANESHARES TR KBA | $3.1m2.32% | — |
| CENTURYLINK INC CTL | $2.9m2.15% | — |
| ANAVEX LIFE SCIENCES CORP AVXL | $1.9m1.39% | — |
| DOW INC DOW | $1.6m1.21% | — |
| MOLECULAR TEMPLATES INC COM | $1.6m1.18% | — |
| SOLIGENIX INC COM | $1.1m0.84% | — |
| DUPONT DE NEMOURS INC DWDP | $963.0k0.71% | — |
| CORTEVA INC CTVA | $887.0k0.65% | — |
| CATASYS INC COM PAR | $702.0k0.52% | — |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |